2 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Withdrawn 2 |
Follow Pulmonary Fibrosis: new trials by email Literature Review of Pulmonary Fibrosis trials Research Report on Pulmonary Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan bosentan - Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis | Phase 4 | Withdrawn | Rajan Saggar | 2007-10-01 | 2018-03-06 | |
| Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil sildenafil - Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis | Phase 4 | Withdrawn | University of California, Los Angeles | 2007-02-01 | 2018-05-01 |
Idiopathic Pulmonary Fibrosis (2) · Pulmonary Arterial Hypertension (2) · Hypertension, Pulmonary (1) · Lung Diseases, Interstitial (1)
Lung Diseases (2) · Respiratory Tract Diseases (2) · Cardiovascular Diseases (1) · Hypertension (1) · Hypertension, Pulmonary (1) · Lung Diseases, Interstitial (1) · Vascular Diseases (1)
Bosentan (1) · Sildenafil Citrate (1)
Rajan Saggar (1) · University of California, Los Angeles (1)
United States (2)
Rajan Saggar, MD (2)